1. Canagliflozin, a Novel SGLT2 Inhibitor for Treatment of Type 2 Diabetes. (October 2013) Authors: Nigro, Stefanie C.; Riche, Daniel M.; Pheng, Michelle; Baker, William L. Journal: Annals of pharmacotherapy Issue: Volume 47:Number 10(2013) Page Start: 1301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗